<DOC>
	<DOCNO>NCT02721368</DOCNO>
	<brief_summary>The purpose study determine whether Neuramis® Volume Lidocaine effective temporary restore mid-face volume .</brief_summary>
	<brief_title>Neuramis® Volume Lidocaine Treatment Patients With Loss Mid-face Volume</brief_title>
	<detailed_description>This study multi-center , randomize , evaluator subject blind , comparative medical device pivotal clinical trial . Efficacy safety evaluate appointed time subject visit clinical site inject medical device .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1 . Male female subject age 35 65 . 2 . Subject want correct his/her midface volume deficit . 3 . Subject agree receive cosmetic procedure cosmetic surgery study period . 4 . Subjects voluntarily decide participation study sign informed consent . 1 . Subjects previous treatment midface restoring volume . 2 . Subjects skin lesion cause congenital defect , trauma lipodystrophy etc . 3 . Subjects hypersensitivity local anesthetic amide type lidocaine . 4 . Pregnant , lactate subject childbearing subject disagree medically acceptable contraception . 5 . Subjects receive investigational product within 4 week prior study participation schedule take part clinical trial study period . 6 . Subjects medical history anaphylaxis severe complex allergy . 7 . Subjects mental disease affect study severe disorder cardiovascular system , digestive system , respiratory system , endocrine system central nervous system . 8 . Patients eligible study medical discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>